- Home
- MRP vs RDNT Comparison
MRP vs RDNT Comparison
Compare MRP & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRP
- RDNT
- Stock Information
- Founded
- MRP N/A
- RDNT 1985
- Country
- MRP United States
- RDNT United States
- Employees
- MRP N/A
- RDNT N/A
- Industry
- MRP
- RDNT Medical Specialities
- Sector
- MRP
- RDNT Health Care
- Exchange
- MRP NYSE
- RDNT Nasdaq
- Market Cap
- MRP 4.1B
- RDNT 3.7B
- IPO Year
- MRP N/A
- RDNT 1986
- Fundamental
- Price
- MRP $25.43
- RDNT $56.61
- Analyst Decision
- MRP Strong Buy
- RDNT Strong Buy
- Analyst Count
- MRP 2
- RDNT 4
- Target Price
- MRP $27.50
- RDNT $69.75
- AVG Volume (30 Days)
- MRP 902.8K
- RDNT 673.3K
- Earning Date
- MRP 05-18-2025
- RDNT 05-12-2025
- Dividend Yield
- MRP 1.46%
- RDNT N/A
- EPS Growth
- MRP N/A
- RDNT N/A
- EPS
- MRP N/A
- RDNT 0.04
- Revenue
- MRP N/A
- RDNT $1,829,664,000.00
- Revenue This Year
- MRP N/A
- RDNT $7.89
- Revenue Next Year
- MRP N/A
- RDNT $9.02
- P/E Ratio
- MRP N/A
- RDNT $1,464.70
- Revenue Growth
- MRP N/A
- RDNT 13.18
- 52 Week Low
- MRP $19.00
- RDNT $45.00
- 52 Week High
- MRP $27.07
- RDNT $93.65
- Technical
- Relative Strength Index (RSI)
- MRP N/A
- RDNT 66.92
- Support Level
- MRP N/A
- RDNT $52.16
- Resistance Level
- MRP N/A
- RDNT $57.71
- Average True Range (ATR)
- MRP 0.00
- RDNT 1.81
- MACD
- MRP 0.00
- RDNT 0.73
- Stochastic Oscillator
- MRP 0.00
- RDNT 92.38
About MRP MILLROSE PROPERTIES INC.
Millrose Properties Inc is a Holding Company. The company along with its subsidiaries engages in providing operational and capital solutions for home builders and land development companies to finance the acquisition and development of land assets through its Homesite Option Purchase Platform.
About RDNT RadNet Inc.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.